Other languages BeyondSpring Inc.

Equities

BYSI

KYG108301006

Delayed Nasdaq Other stock markets 02:22:17 2024-04-30 pm EDT			5-day change	1st Jan Change
2.1 ^USD	-5.41%		-8.30%	+133.33%

Apr. 29	North American Morning Briefing : Investors Brace -2-	DJ
Apr. 22	North American Morning Briefing : Stock Futures -2-	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment	Mar. 25
Beyondspring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in A Phase 2 Investigator-Initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer	Mar. 25
BeyondSpring Inc. Announces Executive Changes	Mar. 18
Top Premarket Decliners	Mar. 06
BeyondSpring Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	Feb. 02
BeyondSpring Receives Non-Compliance Notice From Nasdaq	Jan. 10
BeyondSpring Receives Notification From Nasdaq for Breaching Minimum Bid Price Requirements	Dec. 19
BeyondSpring Inc. Announces New Data That Translates Preclinical Proof-Of-Concept to Clinical Evidence of Plinabulin?s Immunomodulating Activity	Nov. 07
BeyondSpring Inc. Announces Retirement of Yanbin Xie as Board of Director	23-07-14
BeyondSpring Inc. Announces New Data from Phase 1 Investigator Initiated Study Plinabulin’s Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCT	23-06-07
BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18
BeyondSpring Inc. Auditor Raises 'Going Concern' Doubt	23-04-17
BeyondSpring Inc. Enrolls First Patient in Phase 2 Study with Plinabulin, Keytruda and Docetaxel in Patients with Metastatic Non-Small Cell Lung Cancer Who Progressed After Immunotherapy	23-03-01
BeyondSpring Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	23-02-28
Ramon Mohanlal Left Beyondspring Inc. as the Chief Medical Officer and Executive Vice President	23-02-24
BeyondSpring Regains Compliance With Nasdaq's Minimum Bid Price Rule; Gets New Non-Compliance Notice for Delayed Filing	23-01-10
BeyondSpring Inc. Announces the Resignation of Christine Ying Zhao from the Board of Directors, Effective January 1, 2023	22-12-30
Sector Update: Health Care Stocks Flat To Higher Premarket Friday	22-11-25
BeyondSpring Inc. Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022	22-09-13
BeyondSpring Inc. Announces Board Appointments	22-08-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BeyondSpring Inc.

Equities

BYSI

KYG108301006

Other languages

Filters